Evidence map›Paper›PMID 37708378›Full record

ArticleACS infectious diseases2023

Benzene Amide Ether Scaffold is Active against Non-replicating and Intracellular

Sara Ahmed, Sultan Chowdhury, James Gomez, Deborah T Hung, Tanya Parish

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Netupitant Exhibits Potent Activity onACS infectious diseases · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Sara AhmedTB Discovery Research, Infectious Disease Research Institute, Seattle, Washington 98104, United States.
Sultan ChowdhuryTB Discovery Research, Infectious Disease Research Institute, Seattle, Washington 98104, United States.
James GomezBroad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, Massachusetts 02142, United States.ORCID 0000-0003-4262-0673
Tanya ParishTB Discovery Research, Infectious Disease Research Institute, Seattle, Washington 98104, United States.ORCID 0000-0001-7507-0423
Infectious Disease Research Institute · USBroad Institute · US

Funding

High Content Screening of Mycobacterium TuberculosisR01AI132634 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI PARISH, TANYA · 2017 to 2019
$1.9M
NIAID NIH HHS R01 AI132634
6 · The paper itself

Abstract

New drugs to treat tuberculosis which target intractable bacterial populations are required to develop shorter and more effective treatment regimens. The benzene amide ether scaffold has activity against intracellular

Indexed as

Mycobacterium tuberculosisTuberculosisAmidesAntitubercular AgentsBenzeneEtherEthersEthyl EthersHumansMicrobial Sensitivity TestsAmidesAntitubercular AgentsBenzeneEtherEthersEthyl Ethersanti-bacterialanti-tubercularbacterial respirationintracellular infectiontuberculosis

Identifiers

PMID37708378
PMCPMC10580325
OpenAlexW4386734972

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.